Lack of regulations and inadequate testing leave products in question.
Evidence from neurobiological research points to cannabinoids as possible therapeutic agents of interest for PTSD, a condition that over 3.5 million people suffer with in the USA alone.
With the right partners and preparations, any cannabis company can get professional analysis.
To explore, some of the unique aspects of the cannabis industry, Mike May talked with Christina Marrongelli a private consultant and assistant adjunct professor at the University of South Carolina School of Medicine, Department of Drug Discovery and Biomedical Sciences.
As the need for cannabis analysis increases, labs need easier and more complete methods of testing samples.
Whether you are a new lab starting up or a seasoned lab looking to upgrade your old equipment; there are many important aspects you need to think about before deciding to make your equipment purchase.
Bills keep coming up and, so far, getting shot down.
U.S. government examples of cannabis, used in research, fail to replicate the cannabis that's available on the market.
Cannabis testing requirements keep changing in this state, and more adjustments probably lie ahead.